Skip to content

Factor XII Inhibitor (Antithrombin Activity) – Plasma

Published: August 9, 2026Updated: August 16, 2026

This test measures the presence of antibodies that may block the natural blood-clotting process by inhibiting Factor XII, a protein involved in clotting and inflammation pathways. It is often used to diagnose or monitor conditions related to abnormal bleeding or clotting disorders.

Quick summary

["This test helps assess bleeding risks linked to rare clotting disorders caused by Factor XII deficiency or inhibitor presence."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
3230-0
Short code
Fact XII Inhib PPP-aCnc
Synonyms
Fact XII Inhib PPP-aCnc
Category
chemistry
Sample
plasma
Container
Lavender-top (EDTA) or Green-top (Heparin)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
coag
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have unexplained bleeding, prolonged bleeding after injuries or surgeries, or if you have a family history of bleeding disorders. It may also be used in patients suspected of having rare clotting or inflammatory conditions linked to Factor XII.

What to Expect Before the Test

No special preparation is needed. You may have a blood draw from a vein in your arm. If you’re on anticoagulant medications, inform your provider before the test.

What the Test Results Mean

Results are qualitative (positive or negative) and indicate whether Factor XII inhibitor antibodies are present. A positive result suggests a potential bleeding disorder requiring further evaluation.

Common Conditions Monitored

This test helps diagnose or monitor conditions like acquired Factor XII inhibitor syndrome, which can cause bleeding in people with otherwise normal clotting systems.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical significance: Factor XII inhibitors can interfere with normal blood clotting and inflammation processes, potentially leading to excessive bleeding in certain situations. It is particularly relevant for patients with unexplained bleeding or those undergoing procedures requiring precise coagulation control.

Short name

Factor XII Inhibitor

Frequently asked questions

What causes Factor XII inhibitors to develop?
Factor XII inhibitors are typically acquired, often due to autoimmune processes or exposure to certain medications. Rarely, they can occur after trauma or surgery. Family history of bleeding disorders may also increase risk.
How is this test different from standard clotting tests like PT/PTT?
Unlike standard clotting tests (e.g., PT/INR, PTT), this test specifically measures antibodies that directly inhibit Factor XII, a less commonly evaluated clotting factor. It provides targeted insight into rare bleeding disorders.
Can lifestyle changes affect Factor XII inhibitor test results?
No, this test measures antibodies in your blood and is not influenced by lifestyle factors. Results reflect your current immune response to Factor XII.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy